-+ 0.00%
-+ 0.00%
-+ 0.00%

Xencor Extends U.S. Patent Term for Xtend™ Antibodies, Extending Ultomiris Royalties to 2028

路透·12/09/2025 12:01:55

登錄查看新聞詳情